UPDATE: InforMax Shares Climb 32% Following IPO | GenomeWeb

This story has been updated from a previous version with closing prices, analyst comments.

NEW YORK, Oct 3 – Shares of Informax (Nasdaq: INMX) jumped more than 32 percent in their first day of trading on the Nasdaq Tuesday, making it the second successful bioinformatics offering since last week.

But some analysts said the recent strong performance in the bioinformatics sector might be short-lived.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.